Comparison of Global Initiative for Chronic Obstructive Pulmonary Disease 2013 Classification and Body Mass Index, Airflow Obstruction, Dyspnea, and Exacerbations Index in Predicting Mortality and Exacerbations in Elderly Adults with Chronic Obstructive Pulmonary Disease

• Autores: Chiung Zuei Chen, Chih Ying Ou -, Chun-Hsiang Yu, Szu Chun Yang, Han Yu Chang, Tzuen Ren Hsiue
• Localización: Journal of the American Geriatrics Society, ISSN 0002-8614, Vol. 63, Nº. 2, 2015, págs. 244-250
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Objectives To examine whether the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) 2013 revision offers greater predictive ability than the body mass index, airflow obstruction, dyspnea, and exacerbations (BODEx) index in elderly adults with chronic obstructive pulmonary disease (COPD).

    Design Prospective cohort study.

    Setting University-affiliated medical center.

    Participants Taiwanese outpatients with COPD (N = 354).

    Measurements Participants were classified as Group A (low risk with mild dyspnea), Group B (low risk with more-severe dyspnea), Group C (high risk with mild dyspnea), and Group D (high risk with more-severe dyspnea) for GOLD 2013 and from Quartile 1 (0–2 points) to 4 (7–9 points) for BODEx score. Ability to predict exacerbations and mortality was compared using logistic regression analysis with receiver operating characteristic (ROC) curve estimations and area under the ROC curve (AUC).

    Results Mortality was 14.1% for GOLD Group A, 14.5% for Group B, 6.5% for Group C, and 35.8% for Group D and 15.2% for BODEx Quartile 1, 22.5% for Quartile 2, 28.1% for Quartile 3, and 79.2% for Quartile 4. Risk of exacerbation relative to Group A was 1.7 (95% confidence interval (CI) = 0.6–4.3) for Group B, 14.1 (95% CI = 4.6–43.2) for Group C, and 17.9 (95% CI = 7.6–42.0) for Group D. The AUC for the GOLD classification and BODEx index were 0.65 and 0.67 for mortality (P = .60) and 0.79 and 0.73 for exacerbation (P = .03).

    Conclusion The GOLD 2013 classification performed well in identifying individuals at risk of exacerbations, and its predictive ability for exacerbations was better than that of the BODEx index, although the predictive ability for mortality in elderly adults with COPD was poor for both indices.